Requires assessments of the risks and efficacy of algorithms used in adjunctive predictive cardiovascular indicators to analyze cardiovascular vital signs and predict future cardiovascular health.
Requires that adjunctive predictive cardiovascular indicators -- medical devices used to predict cardiovascular health -- be subject to special controls in the U.S. Those controls include the following:
Requires a risk assessment of the device, including full disclosure of software specs and different inputs considered when making predictions about future cardiovascular health.
Requires scientific justification for the device's efficacy, including verification of algorithm calculations and validation using an independent data set.
Requires a human factors and usability engineering assessment to evaluate the risk of misinterpretation of device output.
Requires a clinical data assessment that specifies the clinical data used and an evaluation of output consistency.
Key facts
🏛️ This document has been enacted by the U.S. Food and Drug Administration.
For authoritative text and metadata, visit the official source.
🎯 This document primarily applies to the private sector, rather than the government.
📜 This document's name is 21 CFR § 870.2210 ("Adjunctive predictive cardiovascular indicator").
Themes
AI risks, applications, governance strategies, and other themes addressed in AGORA documents.
This tag applies to documents that address whether humans can understand (a) the mechanisms underlying an AI system’s operation and/or (b) the meaning of the systems’ output in the context of use.
This tag applies to documents that govern whether, how, and/or to what extent people who are affected by or otherwise have an interest in an AI system have access to relevant information about the system.
This tag applies to documents that address the form of disclosure of information about AI systems, such that information is required or encouraged to be disclosed in a prescribed, standardized form intended to make the information easily accessible and understandable.
This tag applies to documents that discuss evaluations that assess whether deployed AI systems meet the expectations specified or claimed prior to deployment.
This tag applies to documents that require or incentivize AI systems to incorporate specific features or achieve (or not achieve) specified results in operation, or to be used or not to be used in specified ways or for specific purposes. Requirements may be defined objectively (e.g., systems must score above a certain level on an established benchmark, systems must incorporate a certain technical feature) or subjectively (e.g., systems must not demonstrate undue bias).
This is an unofficial copy. The document has been
archived and reformatted in plaintext for AGORA. Footnotes, tables, and
similar material may be omitted. For the official text, visit the original source.
§ 870.2210
Adjunctive predictive cardiovascular indicator.
(a) Identification.
The adjunctive predictive cardiovascular indicator is a prescription device that uses software algorithms to analyze cardiovascular
vital signs and predict future cardiovascular status or events. This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.
Identifies a device predicting cardiovascular status using software, intended for adjunctive use.
Identifies a device predicting cardiovascular status using software, intended for adjunctive use.
(b) Classification.
Class II (special controls). The special controls for this device are:
(1) A software description and the results of verification and validation testing based on a comprehensive hazard analysis and risk assessment must be provided, including:
(i) A full characterization of the software technical parameters, including algorithms;
(ii) A description of the expected impact of all applicable sensor acquisition hardware characteristics and associated hardware specifications;
(iii) A description of sensor data quality control measures;
(iv) A description of all mitigations for user error or failure of any subsystem components (including signal detection, signal analysis, data display, and storage) on output accuracy;
(v) A description of the expected time to patient status or clinical event for all expected outputs, accounting for differences in patient condition and environment; and
(vi) The sensitivity, specificity, positive predictive value, and negative predictive value in both percentage and number form.
Requires providing software description, testing results, hazard analysis, risk assessment, and data quality control measures.
Requires providing software description, testing results, hazard analysis, risk assessment, and data quality control measures.
(2) A scientific justification for the validity of the predictive cardiovascular indicator algorithm(s) must be provided. This justification must include verification of the algorithm calculations and validation using an independent data set.
(3) A human factors and usability engineering assessment must be provided that evaluates the risk of misinterpretation of device output.
(4) A clinical data assessment must be provided. This assessment must fulfill the following:
(i) The assessment must include a summary of the clinical data used, including source, patient demographics, and any techniques used for annotating and separating the data.
(ii) The clinical data must be representative of the intended use population for the device. Any selection criteria or sample limitations must be fully described and justified.
(iii) The assessment must demonstrate output consistency using the expected range of data sources and data quality encountered in the intended use population and environment.
(iv) The assessment must evaluate how the device output correlates with the predicted event or status.
Requires scientific justification, human factors evaluation, and comprehensive clinical data assessment for algorithm validation.
Requires scientific justification, human factors evaluation, and comprehensive clinical data assessment for algorithm validation.
(5) Labeling must include:
(i) A description of what the device measures and outputs to the user;
(ii) Warnings identifying sensor acquisition factors that may impact measurement results;
(iii) Guidance for interpretation of the measurements, including a statement that the output is adjunctive to other physical vital sign parameters and patient information;
(iv) A specific time or a range of times before the predicted patient status or clinical event occurs, accounting for differences in patient condition and environment;
(v) Key assumptions made during calculation of the output;
(vi) The type(s) of sensor data used, including specification of compatible sensors for data acquisition;
(vii) The expected performance of the device for all intended use populations and environments; and
(viii) Relevant characteristics of the patients studied in the clinical validation (including age, gender, race or ethnicity, and patient condition) and a summary of validation results.
Requires labeling to describe device function, provide warnings, offer guidance, specify assumptions, and summarize validation results.
Requires labeling to describe device function, provide warnings, offer guidance, specify assumptions, and summarize validation results.